Literature DB >> 10963836

Transdermal delivery of drugs for the treatment of bone diseases.

C Ramachandran1, D Fleisher.   

Abstract

The current status of transdermal drug delivery for the treatment of bone diseases is described in this review. The structure, physiology and function of skin and their importance in determining delivery into and across skin are discussed. Special emphasis has been devoted to a description of the major pathways of transport across the skin and the quite continuing controversy over the importance of the transfollicular route. An overview of anatomic site-dependent drug absorption is also provided and is particularly relevant to determination of transdermal patch location. Brief descriptions of the criteria for selection of transdermal drug candidate, transdermal patch designs and currently marketed transdermal products are also included. Transdermal estradiol delivery systems are examined in more detail for their clinical and biological effects. Finally, the feasibility of delivering drugs such as bisphosphonates across skin is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963836     DOI: 10.1016/s0169-409x(00)00062-4

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  7 in total

1.  Effect of direction (epidermis-to-dermis and dermis-to-epidermis) on the permeation of several chemical compounds through full-thickness skin and stripped skin.

Authors:  Takeshi Oshizaka; Hiroaki Todo; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

Review 2.  Advances in Controlled Drug Delivery for Treatment of Osteoporosis.

Authors:  T A Asafo-Adjei; A J Chen; A Najarzadeh; D A Puleo
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

3.  Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.

Authors:  S Hariharan; V Bhardwaj; I Bala; J Sitterberg; U Bakowsky; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

Review 4.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Fumarate copolymers-based membranes overlooking future transdermal delivery devices: synthesis and properties.

Authors:  Magalí Pasqualone; Tamara G Oberti; Héctor A Andreetta; M Susana Cortizo
Journal:  J Mater Sci Mater Med       Date:  2013-04-16       Impact factor: 3.896

7.  A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.

Authors:  Sallwa M Alshehre; Sheila Duffy; Georgina Jones; William L Ledger; Mostafa Metwally
Journal:  Reprod Biol Endocrinol       Date:  2020-04-14       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.